Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis

INTRODUCTION: Patients aged ≥ 65 years continue to be underrepresented in clinical studies related to type 2 diabetes mellitus (T2DM). Accordingly, the REALI pooled analysis was performed to evaluate the effectiveness and safety of insulin glargine 300 U/mL (Gla-300) across different age subgroups,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonadonna, Riccardo C., Mauricio, Didac, Müller-Wieland, Dirk, Freemantle, Nick, Bigot, Gregory, Mauquoi, Celine, Ciocca, Alice, Bonnemaire, Mireille, Gourdy, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994463/
https://www.ncbi.nlm.nih.gov/pubmed/33650085
http://dx.doi.org/10.1007/s13300-021-01030-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994463/
https://www.ncbi.nlm.nih.gov/pubmed/33650085
http://dx.doi.org/10.1007/s13300-021-01030-0

Ejemplares similares